GlassScriptPhysician profile
Charles A Cole
NPI 1447302690
$6,583.93
in general payments reported to CMS, 2019-2025
24 companies · $1,444 in 2025
The $1,444 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $330 · 2021: $179 · 2022: $1,289 · 2023: $981 · 2024: $1,607 · 2025: $1,444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,319 · Travel and Lodging: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,318.57 |
| Travel and Lodging | $714.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,018.98 | 2019-2025 | Unity, Rocklatan, Clareon Panoptix Pro |
| Abbvie INC. | $1,864.25 | 2022-2025 | Durysta, Xen Glaucoma Treatment System, Lumigan |
| Glaukos Corporation | $572.72 | 2019-2025 | Radius Xr, Istent Infinite, Idosetr |
| Sun Pharmaceutical Industries INC. | $251.09 | 2019-2023 | Cequa |
| Oyster Point Pharma, INC. | $249.08 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Dompe US, INC. | $181.61 | 2024-2025 | Oxervate |
| Sight Sciences, INC. | $181.09 | 2023-2024 | Omni Surgical System, Tearcare System |
| Allergan, INC. | $176.34 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $165.81 | 2022-2024 | Vyzulta, Xiidra, Miebo |
| Johnson & Johnson Surgical Vision, INC. | $137.92 | 2024 | Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $128.71 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $119.33 | 2024-2025 | Xdemvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.17 | 2025 | |
| New World Medical,INC. | $88.06 | 2023-2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $34.03 | 2019-2021 | |
| Omeros Corporation | $32.52 | 2019 | |
| Aerie Pharmaceuticals, INC. | $32.02 | 2019 | |
| Rayner Intraocular Lenses Limited | $22.56 | 2023 | Omidria, Rayone Aspheric, Rayone Emv |
| Spark Therapeutics, INC. | $20.24 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Thea Pharma INC. | $18.32 | 2023 | |
| Ocular Therapeutix, INC. | $15.17 | 2021 | |
| Eyevance Pharmaceuticals LLC | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.